VT
BIIB icon

Vise Technologies’s Biogen BIIB Stock Holding History

Vise Technologies’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
6,627
+1,212
+22% +$232K 0.02% 644
2026
Q1 		$953K Hold
5,415
– – 0.02% 604
2025
Q4 		$953K Buy
5,415
+2,616
+93% +$427K 0.02% 608
2025
Q3 		$392K Sell
2,799
-371
-12% -$50.1K 0.01% 785
2025
Q2 		$398K Buy
+3,170
New +$395K 0.02% 726
2024
Q4 		$250K Buy
+1,636
New +$276K 0.02% 679
2023
Q3 		– Sell
-716
Closed -$204K – 332
2023
Q2 		$204K Sell
716
-19
-3% -$5.66K 0.05% 324
2023
Q1 		$204K Buy
+735
New +$203K 0.05% 321

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vise Technologies's BIIB Position: Q2 2026 in Review

Vise Technologies increased its Biogen (BIIB) stake by 22% in Q2 2026, buying an estimated $232K and bringing the position to 6,627 shares worth $1.43M. The position accounts for 0.02% of the portfolio, ranked #644.

Vise Technologies first reported a position in BIIB in Q1 2023 and has held it in 8 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Vise Technologies held 6,627 shares of Biogen worth $1.43M as of Q2 2026.
  • Vise Technologies bought 1,212 Biogen shares in Q2 2026, an estimated $232K.
  • Biogen made up 0.02% of Vise Technologies's portfolio in Q2 2026, its #644 holding.
  • Vise Technologies first reported a position in Biogen in Q1 2023 and has held it in 8 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.